Medeloop

Palo Alto, United States Founded: 2021 • Age: 5 yrs
Drug discovery services are offered by Medeloop as a CRO.

About Medeloop

Medeloop is a Healthcare company based in Palo Alto (United States) founded in 2021 by Rene Caissie. Drug discovery services are offered by Medeloop as a CRO. Medeloop has raised $23.5 million across 2 funding rounds from investors including Icon Ventures, Inovia Capital and General Catalyst. Its chief executive, as recorded, is Rene Caissie. Medeloop offers products and services including Analytics Genius, Studies Genius, and Grants Genius. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Cell and Molecular Biology. Its legal entity is MEDELOOP INC. Its competitors include Hyku Biosciences, Centivax and Biolexis Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Medeloop was established in 2021 in Palo Alto, United States, as a contract research organization in the biotechnology sector. Drug discovery services are provided to support pharmaceutical development. Operations are centered on advancing research processes for clients. The company is led by co-founder and CEO Rene Caissie. Focus remains on efficient, data-driven solutions in the life sciences field.

  • Headquarters Palo Alto, United States
  • Founders Rene Caissie
  • Sectors
    Healthcare
  • Website medeloop.ai
  • Social LinkedIn
  • Legal Name Medeloop Inc
Key Metrics
  • Total Equity Funding
    $23.5M (USD)

    in 2 rounds

  • Latest Funding Round
    $15.5M (USD), Series A

    Oct 2024

  • Investors

Products & Services of Medeloop

Medeloop offers a comprehensive portfolio of products and services, including Analytics Genius, Studies Genius, and Grants Genius.

Analytics Genius
Data Analysis Platform

AI tool for analyzing datasets without coding and extracting insights

Studies Genius
Study Management Platform

Platform for collecting, monitoring, and automating study data

Grants Genius
Grant Writing Tool

AI for matching grants and generating proposals quickly

Funding Insights of Medeloop

Medeloop has successfully raised a total of $23.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $23.5M
  • Total Rounds 2
  • Last Round Series A β€” $15.5M
  • First Round $8M

    (Sep 2023)

  • Investors Count 10

All 2 funding rounds of Medeloop with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2024$15.5MSeries A–Inovia Capital
Sep 2023$8MSeed–General Catalyst
Valuation history

10 investors in total: 8 institutional and 2 angel.

Investors in Medeloop

Medeloop has secured backing from 10 investors, including venture fund and angel investors. Prominent investors backing the company include Icon Ventures, Inovia Capital and General Catalyst.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Investments are made in early-stage technology companies by Inovia Capital.
inovia.vcMontreal, Canada
Sector-agnostic growth stage VC investment company funding companies in the US and Asia
1992iconventures.comPalo Alto, United States
Investment and transformation services for entrepreneurs in technology and finance sectors.
generalcatalyst.com
Seed-stage investments in technology companies are made by Maven Ventures.
mavenventures.comPalo Alto, United States
Healthier Capital is focused on healthcare technology venture investments.
healthiercapital.com
Operational excellence and financial consulting are provided by CFO Advisors.
cfoadvisors.com
Seed & early stage sector-agnostic VC firm funding companies in the US
ovofund.comPalo Alto, United States

Ken Frazier

unknown_10e92a1d1efa4bc89

Linda Grais

Angel investor and advisor, focused on early-stage Indian startups.
unknown_f7d33a31ad5b4d439
Up2 Foundation is focused on developing servant leaders through media and events.
up2foundation.orgLakewood, United States
Premium access

Investor details for Medeloop

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Medeloop

17 people are tracked at Medeloop (6 in leadership, 11 in team).

NameRoleGroup
Rene Caissie
Co-Founder & CEOLeadership
Ashley Moseby
Head Of SalesLeadership
Santiago C.
VP Of EngineeringLeadership
Lauren Green
Chief Of StaffLeadership
Santiago Cardenas
VP Of EngineeringLeadership
Alex Wu
Head Of Finance & StrategyLeadership
Jose Lavrador
Senior Software EngineerTeam
Vishaal Yalamanchali
Machine Learning EngineerTeam
Boqian Cheng
Senior Mobile EngineerTeam
Rene Leyva
Senior Software EngineerTeam
Kaci Madden
Product ManagerTeam
Yorick Chern
Machine Learning EngineerTeam
Avi Udash
Founding Software EngineerTeam
Olushola Adedokun
Software Engineering ManagerTeam
Daniela Cappa
Executive AssistantTeam
Mohamed Lamouchi
Software Engineering Team LeadTeam
Oliver Perez
Senior Mobile EngineerTeam
Premium access

Complete people profiles for Medeloop

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Medeloop

3 dated milestones of Medeloop across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Medeloop is founded.
  2. Funding First funding round of $8.0M.
  3. Funding Latest funding round, Series A, of $15.5M.

Competitors of Medeloop

Medeloop has 3 listed competitors in our database, 3 of them funded. They include Hyku Biosciences, Centivax and Biolexis Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
hykubiosciences.com2023Lexington, United States$56M
Covalent medicines platform is advanced for drug discovery targeting proteins.
centivax.com2019San Francisco, United States$55M
Drug discovery services are provided to pharmaceutical and biotech clients.
biolexistx.com2021Salt Lake, United States$12.5M
CRO focused on drug discovery of small molecule therapeutics
Premium access

Detailed competitors of Medeloop

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Medeloop

The website of Medeloop (medeloop.ai) receives about 3.6K visits a month.

  • Monthly visits
    3.6K

    ▲ 112.6% vs previous month

Similar websites

Websites whose visitors overlap most with Medeloop. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
healthverity.com
100%
10.2K#2,336,457View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Medeloop (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Medeloop

Premium access

Complete news archive for Medeloop

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medeloop

Medeloop was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Medeloop is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

Rene Caissie is the CEO of Medeloop, as recorded in our data. They have also founded this company.

Medeloop is a funded company, having raised a total of $23.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $8M, raised on Sep 2023.

Medeloop was established in 2021 in Palo Alto, United States, as a contract research organization in the biotechnology sector. Drug discovery services are provided to support pharmaceutical development. Operations are centered on advancing research processes for clients. The company is led by co-founder and CEO Rene Caissie. Focus remains on efficient, data-driven solutions in the life sciences field.

Medeloop's top competitors include Centivax, Hyku Biosciences and Biolexis Therapeutics.

Medeloop offers Analytics Genius, Studies Genius, and Grants Genius.

Medeloop has 10 investors. Key investors include Icon Ventures, Inovia Capital, General Catalyst, Maven Ventures, and Healthier Capital.

Medeloop operates through Medeloop Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available